Tailor Bio
PrivateLast Round
Seed
Feb 7, 2023
Total Funding Raised
$5.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tailor Bio is a biotechnology company that operates an AI-driven drug discovery platform for pan-cancer precision medicine, focusing on identifying chromosomal instability (CIN) signatures to predict patient response to cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tailor Bio Comparables
Compare Tailor Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessellate BIO | 74% | |
| Volastra Therapeutics | 73% | |
| Roche Holding | 70% |
Tailor Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 7, 2023 | ||||
| Seed | Nov 30, 2022 | ||||
| Grant | Jul 11, 2022 | ||||
| Grant | Jun 29, 2020 | ||||
| Accelerator | Jun 22, 2020 |
Tailor Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Ascension Ventures | Seed |
| Acequia Capital | Seed |
| First In | Seed, Accelerator |
| Cambridgeshire & Peterborough Combined Authority | Seed, Accelerator |
| Acequia Capital | Seed |
| Time Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 66% MoM.
- Apr 22, 2026
Monthly visitors grew 1069% MoM, reaching 1.1K.
Tailor Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tailor Bio's valuation, stock price, and market status.
Is Tailor Bio a public or private company?
Tailor Bio is a private company.
What is the current stock price of Tailor Bio?
Tailor Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Tailor Bio worth (valuation)?
Valuation information for Tailor Bio is not publicly available.
Can I buy Tailor Bio stock?
Tailor Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tailor Bio's last funding round?
Tailor Bio's most recent funding round was Seed on November 30, 2022.
Who are the main investors in Tailor Bio?
Key investors in Tailor Bio include Innovate UK, First In Ventures, Cambridgeshire & Peterborough Combined Authority, Acequia Capital, Time Partners.
Will Tailor Bio IPO soon?
No public IPO plans have been announced for Tailor Bio.
How can I track Tailor Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tailor Bio's secondary market activity and sign up for updates.